Review of an article: The ADVANCE Collaborative Group. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. NEJM 2008;358:2560-2572.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Vascular Nursing

• Publication date

  2008-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JVN.2008.08.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper

• ЕВРАЗИЙСКИЕ РЕКОМЕНДАЦИИ ПО ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У БОЛЬНЫХ С ДИАБЕТОМ И ПРЕДИАБЕТОМ (2021)

  2021cites this paper
• Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension: an observational study

  2020cites this paper
• Diabetes and the Nervous System

  2020cites this paper
• Pharmacological treatment of increased vascular risk and cognitive performance in middle-aged and old persons: six-year observational longitudinal study

  2020cites this paper
• Prevalence of Incretin-Mimetic and Sodium-Glucose-Transporter-2-Inhibitor Therapy in German Hospitalized Type-2 Diabetics Following Myocardial Revascularization: An Observational Study

  2020cites this paper
• Cardiovascular Disease Prevention in Women

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study

  2020cites this paper
• The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus

  2019cites this paper
• Effects of sarpogrelate on microvascular complications with type 2 diabetes

  2019cites this paper
• Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases

  2019cites this paper
• Glycemic Metrics and Targets in Kidney Disease

  2019cites this paper
• Evidence-Based Cardiovascular Risk Management in Diabetes

  2019cites this paper
• Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis

  2019cites this paper
• Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project

  2019cites this paper
• Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now?

  2019cites this paper
• The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes

  2019cites this paper
• Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs

  2019cites this paper
• Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment

  2019cites this paper
• GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION

  2019cites this paper
• Editor’s Pick: How Can We Develop More Effective Strategies for Type 2 Diabetes Mellitus Prevention? A Paradigm Shift from a Glucose-Centric to a Beta Cell-Centric Concept of Diabetes

  2018cites this paper
• Sind manche Antidiabetika besser als andere?

  2018cites this paper
• Cardiovascular Outcomes Trials Update: Insights from the DEVOTE Trial

  2018cites this paper
• Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal Association

  2018cites this paper
• Treatment with Oral Drugs

  2018cites this paper
• Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

  2018cites this paper
• Type 2 diabetes and cardiovascular prevention: the dogmas disputed

  2018cites this paper
• Shared Genetic Contribution of Type 2 Diabetes and Cardiovascular Disease: Implications for Prognosis and Treatment

  2018cites this paper
• The safety and efficacy of once-weekly glucagon-like peptide-1 receptor agonist semaglutide in patients with type 2 diabetes mellitus: a systemic review and meta-analysis

  2018cites this paper
• Antidiabetika bei älteren, multimorbiden Patienten

  2017cites this paper
• Assessing Cardiovascular Risk and Testing in Type 2 Diabetes

  2017cites this paper
• Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in time to do more in diabetes

  2017cites this paper
• Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%

  2017cites this paper
• Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats

  2017cites this paper
• Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03)

  2017cites this paper
• Glycaemic, Blood Pressure and Low Density Lipoprotein Cholesterol Control in Adult Patients with Diabetes in Singapore: A Review of Singapore Literature Over Two Decades.

  2017cites this paper
• Palliative and end of life care of people with diabetes: Issues, challenges and strategies.

  2017cites this paper
• Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors

  2016cites this paper
• The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease

  2016cites this paper
• Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy

  2016cites this paper
• Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

  2016cites this paper
• MICRO- AND ULTRASTRUCTURE TESTIS OF WHITE RAT IN NORMAL CONDITION AND IN CASE OF STREPTOZOTOZIN INDUCATION DIABETES

  2016cites this paper
• Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis

  2016cites this paper
• Tratamiento hipoglucemiante en pacientes con diabetes mellitus tipo 2 con insuficiencia cardiaca estable o cardiopatõ´a isquemica sin insuficiencia cardiaca Treatment guidelines for hyperglycaemia in type 2 diabetes patients with stable chronic heart failure or ischemic cardiomyopathy without heart

  2016cites this paper
• Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report

  2016cites this paper
• Correlation Between the Severity of Diabetic Peripheral Polyneuropathy and Glycosylated Hemoglobin Levels: A Quantitative Study

  2016cites this paper
• Clinical and pathological analysis of renal damage in elderly patients with type 2 diabetes mellitus

  2016cites this paper
• Ileal Interposition with Sleeve Gastrectomy for the Treatment of Type 2 Diabetes

  2016cites this paper
• Type 2 Diabetes Mellitus: Beyond the Beta Cell

  2016cites this paper
• ACE I/D (Rs1799752), MTHFR C677T (Rs1801133), and CCR5 D32 (Rs333) Genes and their Association with Hypertension and Diabetic Nephropathy in Urban Areas of Costa Rica, Nicaragua, and Mexico

  2016cites this paper
• Surgical Options in Type 2 Diabetes

  2015cites this paper
• CM Tools and Pearls: The Canadian Diabetes Association 2013 Clinical Practice Guidelines

  2015cites this paper
• Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

  2015cites this paper
• Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes

  2015cites this paper
• [Sulfonylureas in today's blood glucose lowering therapy. New data on advantages and potential barriers of an "old" antidiabetic group].

  2015cites this paper
• ADVANCE‐ON: further support for intensive glucose control in type 2 diabetes

  2015cites this paper
• Effects of α-blocker therapy on active duty military and military retirees for benign prostatic hypertrophy on diabetic complications.

  2015cites this paper
• Endocrine Heart Diseases

  2015cites this paper
• II. Disorder of Carbohydrate Metabolism

  2015cites this paper
• Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.

  2015cites this paper
• Management of Glycemia in Diabetic Patients with Stage IV and V Chronic Kidney Disease

  2015cites this paper
• Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

  2015cites this paper
• There is level 1 evidence for intensive glycemic control for reducing the progression of diabetic retinopathy in persons with type 2 diabetes

  2015cites this paper
• Paradox of using intensive lowering of blood glucose in diabetics and strategies to overcome it and decrease cardiovascular risks

  2015cites this paper
• Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.

  2015cites this paper
• Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database

  2015cites this paper
• Sex-Specific Differential in Risk of Diabetes-Related Macrovascular Outcomes

  2015cites this paper
• [The metabolic memory phenomenon in predicting a risk for vascular complications in diabetes mellitus].

  2015cites this paper
• Diabetes Medications and Bone

  2015cites this paper
• The effects and safety of vildagliptin on cardiac function after acute myocardial infarction.

  2015cites this paper
• Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men.

  2015cites this paper
• Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study.

  2015cites this paper
• Predicting risk of severe hypoglycaemia in type 2 diabetes

  2015cites this paper
• Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice

  2015cites this paper
• The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment

  2015cites this paper
• The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.

  2015cites this paper
• Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24‐week results from the observational study in routine clinical practice

  2015cites this paper
• Preventing the Progression of Diabetic Kidney Disease

  2014cites this paper
• Hypoglycemia with Insulin and Parenteral Nutrition

  2014cites this paper
• Evaluating Cardiovascular Safety of Novel Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus

  2014cites this paper
• Update in Therapeutic Approaches to Plaque Stabilization

  2014cites this paper
• Coronary triglyceride deposition in contemporary advanced diabetics

  2014cites this paper
• Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data

  2014cites this paper
• Is diabetic nephropathy reversible?

  2014cites this paper
• The prognosis of patients with coronary artery disease complicated by postload hyperinsulinemia

  2014cites this paper
• Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?

  2014cites this paper
• Éducation thérapeutique du patient âgé ayant un diabète : quelle adaptation de la démarche éducative aux enjeux du vieillissement ?

  2014cites this paper
• Treatment of Mild Hypoglycemia

  2014cites this paper
• Optimal utilisation of sulphonylureas in resource-constrained settings

  2014cites this paper
• Vom HbA1c zum Gesamtrisiko

  2014cites this paper
• Glycaemic Therapy for Diabetes

  2014cites this paper
• Aspectos clínicamente relevantes para pacientes diabéticos en tratamiento con insulina: prevención de hipoglucemias y flexibilidad en la administración

  2014cites this paper
• Age of diabetes diagnosis and diabetes duration associate with glycated haemoglobin.

  2014cites this paper
• 4.1 Pathogenese des Diabetes mellitus Typ 2 - 109 4.2 Die Rolle der Mitochondrien bei Diabetes mellitus - 113 4.3 Postprandiale Hyperglykämie, subklinische Inflammation und endotheliale Dysfunktion - 115 4.4 Übergewicht und metabolisches Syndrom - 122

  2014cites this paper
• Facteurs associés au mauvais contrôle glycémique dans une population de diabétiques de type 2 de l’Afrique Sub-saharienne

  2014cites this paper
• Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial

  2014cites this paper
• Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty

  2014cites this paper
• Diabetic nephropathy—emerging epigenetic mechanisms

  2014cites this paper
• Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy

  2014cites this paper
• FACTEURS INFLUENÇANT L'AUTOGESTION DU DIABÈTE : PERCEPTIONS DES ADULTES DIABÉTIQUES DE TYPE 2 INSULINOTRAITÉS

  2014cites this paper